• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Nectar Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23920.0
  • ISIN : INE023H01027
11.00 0 (-3.00%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    10.80

  • Today’s High

    11.65

  • Open

    11.65

  • Perv Close

    11.34

  • 52W Low

    9.30

  • 52W High

    22.40

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    213.69

  • Div & Yield %

    0.00

  • Book Value(₹)

    29.98

  • Debt-Equity Ratio

    -3.00

  • AGM Date

    14-Aug-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.65

  • Mar.Cap (₹Cr.)

    213.69

  • RONW (%)

    0.47

  • ROCE (%)

    5.96

Score Board

  • Equity (₹ in Cr.)

    19.43

  • BV (₹)

    30.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -57.34

  • NP Var(%)

    50.0

  • Div%

    0.0

  • CPS (₹)

    -2.90

  • EPS (₹)

    -3.00

  • Traded Value (₹ in Lakhs)

    218.93

  • 52 Week High

    22.40

  • 52 Week Low

    9.30

  • Price BSE

    11.0

  • Price NSE

    11.00

  • Market Capital( in Cr.)

    218.93

  • P/C Ratio

    -3.70

  • P/E Ratio

    -3.70

  • Price Vs.BV

    -3.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,908.40 1,925.83 1,746.56 1,924.92 1,762.27 2,639.28
Excise Duty 238.43 241.75 222.89 256.69 220.45 276.48
Net Sales 1,669.97 1,684.08 1,523.67 1,668.23 1,541.82 2,362.80
Other Income 4.99 14.58 43.18 11.32 3.79 4.32
Stock Adjustments -117.29 40.21 41.64 -14.97 -102.80 5.25
Total Income 1,557.67 1,738.87 1,608.49 1,664.58 1,442.81 2,372.37
EXPENDITURE :            
Raw Materials 1,250.72 1,242.45 1,200.84 1,207.32 1,052.82 1,862.83
Power and Fuel Cost 104.16 129.52 127.39 101.41 84.63 92.72
Employee Cost 93.61 81.71 75.14 71.91 70.55 78.19
Other Manufacturing Expenses 59.25 55.30 44.88 45.09 44.16 46.39
Selling and Administration Expenses 71.17 61.38 61.01 66.82 72.00 66.18
Miscellaneous Expenses 3.33 2.37 1.32 1.90 31.04 3.72
Employee Benefit Expenses 93.61 81.71 75.14 71.91 70.55 78.19
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,582.24 1,572.73 1,510.59 1,494.44 1,355.19 2,150.04
Operating Profit -24.57 166.13 97.91 170.13 87.63 222.33
Interest 74.58 87.14 79.48 78.81 112.03 125.82
Gross Profit -99.15 78.99 18.43 91.32 -24.40 96.51
Depreciation 62.39 60.72 59.12 56.97 60.25 60.77
Profit Before Tax -161.54 18.27 -40.69 34.35 -84.65 35.74
Current Tax -47.85 13.27 -18.24 9.03 -11.50 1.66
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 4.02
Reported Net Profit -113.68 5.00 -22.46 25.32 -73.15 30.06
Extraordinary Items 0.02 0.18 40.51 9.41 -25.41 0.22
Adjusted Net Profit -113.70 4.82 -62.97 15.91 -47.74 29.84
Adjustment below Net Profit 0.54 -0.34 0.19 0.81 0.00 1.26
P & L Balance brought forward 703.93 699.27 721.54 695.41 766.26 739.31
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 1.12 1.35
P & L Balance carried down 590.79 703.93 699.27 721.54 691.99 769.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.05
Earnings Per Share-Unit Curr -5.07 0.22 -1.00 1.13 -3.26 1.34
Earnings Per Share(Adj)-Unit Curr -5.07 0.22 -1.00 1.13 -3.26 1.34
Book Value 42.63 47.68 47.47 48.46 47.30 50.59
Book Value(Adj)-Unit Curr 42.63 47.68 47.47 48.46 47.30 50.59

Shareholding Pattern

  • Promoter Group

    51.84%

  • Public Share Holding

    48.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,706,448 51.84 100,706,448 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 100,706,448 51.84 100,706,448 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 44,020 0.02 44,020 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 973,592 0.50 973,592 9
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,831 0.00 3,831 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,267,763 3.74 7,267,763 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,289,206 4.27 8,289,206 14
2] Non Institution
Bodies Corporate 5,702,710 2.94 5,702,700 250
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,912,312 0.98 1,912,312 640
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,412,881 2.27 4,412,881 1,658
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,418,393 1.76 3,418,393 8
Individuals holding nominal share capital up to Rs. 1 lakh 69,578,940 35.82 69,578,830 71,258
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 65,000 0.03 65,000 1
Others 174,580 0.09 174,580 1
Sub Total 85,265,316 43.89 85,265,196 73,817
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 194,260,970 100.00 194,260,850 73,834

Company Background

Nectar Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Nectar Lifescience Ltd
  • BSE Code : 23920.0
  • ISIN : INE023H01027

  • Incorporation Year

    1995

  • Registered Office

    Village Saidpura
    Tehsil Derabassi S A S Nagar, Mohali,
    Punjab-140507

  • Telephone

    91-1762-308000

  • FAX

    91-1762-308135

  • Chairman

    Sanjiv Goyal

  • Managing Director

    Sanjiv Goyal

  • Company Secretary

    Sanjaymohan Singh Rawat

  • Auditor

    Deepak Jindal & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Nectar Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Nectar Lifesci. 11.27 1,674.97 1,908.40 -0.75 -5.33
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77